TAO Synergies (TAOX) Stock Analysis

What TAO Synergies does

TAO Synergies Inc. operates as a biopharmaceutical company currently in the clinical development stage. It is dedicated to advancing a bryostatin-1 therapeutic platform, specifically designed to combat Alzheimer's and various other neurodegenerative and cognitive disorders. Beyond its drug development efforts, the firm is also diversifying its treasury strategy, with a new approach centered on the management of digital assets, primarily focusing on the acquisition and 'staking' of TAO cryptocurrency.

Key metrics

ETFs linked to TAOX

Broad-market and Technology sector ETFs an investor holding TAO Synergies is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how TAOX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for TAO Synergies?

TAO Synergies trades under the ticker TAOX on NASDAQ.

Which exchange is TAOX listed on?

TAOX is listed on NASDAQ.

What sector does TAO Synergies operate in?

TAO Synergies is classified in the Technology sector (Software - Application industry).

How can PortView help analyze TAOX in a portfolio?

PortView shows TAOX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.